Ikaria Holdings: FDA Accepts Final Section of NDA Filing for LUCASSIN(R)
6/12/2009 8:38:00 AM
More...
|
Ikaria Inc. Acquires North American Rights to LUCASSIN(R) From Orphan Therapeutics, LLC
9/2/2008 10:08:26 AM
More...
|
Orphan Therapeutics, LLC Announces Initiation of Rolling NDA Submission for LUCASSIN(R) (terlipressin) for the Treatment of Hepatorenal Syndrome Type 1
5/28/2008 10:58:52 AM
More...
|
PDL BioPharma, Inc. (PDLI) And Orphan Therapeutics, LLC End Collaboration Agreement For Terlipressin
12/19/2006 1:02:07 PM
More...
|
Orphan Therapeutics, LLC Announces Rolling NDA Submission For LUCASSIN(TM) (terlipressin) To Treat Type 1 Hepatorenal Syndrome
12/18/2006 1:39:00 PM
More...
|
Jazz Pharmaceuticals, Inc. To Buy Orphan Medical, Inc. (ORPH) For About $122.6 Million In Cash
10/19/2005 5:13:08 PM
More...
|
Protein Design Labs, Inc. (PDLI) And Orphan Therapeutics, LLC Report Fast Track Designation For Terlipressin In Type 1 Hepatorenal Syndrome
10/19/2005 5:13:02 PM
More...
|